Contact

All Stories

  1. Salt-enhanced natural deep eutectic solvent microextraction: Eco-friendly tilmicosin detection in food

    Article • Talanta Open, December 2026, Elsevier

    Dr. Moataz Ahmed Shaldam

  2. Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategies

    Article • Drug Discovery Today, December 2026, Elsevier

    Dr. Moataz Ahmed Shaldam

  3. Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active Against Helicobacter pylori

    Article • Antibiotics, July 2026, MDPI AG

    Dr. Moataz Ahmed Shaldam

  4. Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR Inhibitors

    Article • Drug Development Research, May 2026, Wiley

    Wagdy Eldehna, Dr. Moataz Ahmed Shaldam

  5. Thiazole‐Semicarbazone Hybrids as Dual‐Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights

    Article • Drug Development Research, March 2026, Wiley

    Wagdy Eldehna, Dr. Moataz Ahmed Shaldam

  6. Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- Mycobacterium tuberculosis agents

    Article • RSC Medicinal Chemistry, January 2026, Royal Society of Chemistry

    Dr. Moataz Ahmed Shaldam

  7. Design and synthesis of 1,3,4-oxadiazole-tethered N -substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and in silico

    Article • RSC Advances, January 2026, Royal Society of Chemistry

    Dr. Moataz Ahmed Shaldam

  8. Tailored [1,2,4]triazolo[1,5- a ]pyrimidine hybrids as promising anti-inflammatory agents with COX/5-LOX/ROS/IL-6 multifunctional inhibitory activity: design, synthesis, SAR, and in ...

    Article • RSC Advances, January 2026, Royal Society of Chemistry

    Dr. Moataz Ahmed Shaldam

  9. Potential of MAO-B Inhibitors with Multi-target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative Disorders

    Article • Mini-Reviews in Medicinal Chemistry, January 2026, Bentham Science Publishers

    Dr. Moataz Ahmed Shaldam

  10. Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity

    Article • Pharmaceuticals, November 2025, MDPI AG

    Wagdy Eldehna, Dr. Moataz Ahmed Shaldam

  11. Correction: Khayyat et al. Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens. Microorganisms 2021, 9, 1083

    Article • Microorganisms, September 2025, MDPI AG

    Dr. Moataz Ahmed Shaldam

  12. Antimicrobial and Anti-Efflux Machinery of FDA-Approved Proton Pump Inhibitors and Vitamins Against Klebsiella pneumoniae and Pseudomonas aeruginosa

    Article • Microorganisms, May 2025, MDPI AG

    Dr. Moataz Ahmed Shaldam

  13. Mechanistic and Molecular Insights into Empagliflozin’s Role in Ferroptosis and Inflammation Trajectories in Acetaminophen-Induced Hepatotoxicity

    Article • Pharmaceuticals, March 2025, MDPI AG

    Dr. Moataz Ahmed Shaldam

  14. Donepezil-based rational design of N-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studies

    Article • RSC Medicinal Chemistry, January 2025, Royal Society of Chemistry

    Dr. Moataz Ahmed Shaldam

  15. Targeted synthesis of a trimethoxyphenyltetrahydropyrimidine analogue designed as a DNA intercalator: in silico, multi-spectroscopic, thermodynamic, and in vitro approaches

    Article • RSC Advances, January 2025, Royal Society of Chemistry

    Dr. Moataz Ahmed Shaldam

  16. Unlocking the potential of eggplant peel: Powerful peroxidase nanozyme for l-cysteine determination in pharmaceutical supplements

    Article • Microchemical Journal, December 2024, Elsevier

    Dr. Moataz Ahmed Shaldam

  17. Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations

    Article • Journal of Molecular Structure, August 2024, Elsevier

    Wagdy Eldehna, Dr. Moataz Ahmed Shaldam

  18. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles

    Article • Journal of Medicinal Chemistry, April 2024, American Chemical Society (ACS)

    Dr. Moataz Ahmed Shaldam

  19. DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras

    Article • PLOS One, March 2024, PLOS

    Wagdy Eldehna, Ahmed Sabt, Dr. Moataz Ahmed Shaldam

  20. Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity

    Article • RSC Advances, January 2024, Royal Society of Chemistry

    Wagdy Eldehna, Dr. Moataz Ahmed Shaldam

  21. Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments

    Article • Journal of Medicinal Chemistry, December 2023, American Chemical Society (ACS)

    Dr. Moataz Ahmed Shaldam

  22. Metolazone co-crystals-loaded oral fast dissolving films: Design, optimization, and in vivo evaluation

    Article • Journal of Drug Delivery Science and Technology, December 2023, Elsevier

    Dr. Moataz Ahmed Shaldam

  23. Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights

    Article • Bioorganic Chemistry, November 2023, Elsevier

    Dr. Moataz Ahmed Shaldam, Wagdy Eldehna

  24. Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity

    Article • Archiv der Pharmazie, October 2023, Wiley

    Dr. Moataz Ahmed Shaldam, Wagdy Eldehna

  25. 1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities

    Article • Journal of Medicinal Chemistry, July 2023, American Chemical Society (ACS)

    Dr. Moataz Ahmed Shaldam

  26. Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2023, Taylor & Francis

    Dr. Moataz Ahmed Shaldam

  27. Protective Potential of Saussurea costus (Falc.) Lipsch. Roots against Cyclophosphamide-Induced Pulmonary Injury in Rats and Its In Vitro Antiviral Effect

    Article • Pharmaceuticals, February 2023, MDPI AG

    Dr. Moataz Ahmed Shaldam

  28. Synthesis, crystallographic, DNA binding, and molecular docking/dynamic studies of a privileged chalcone-sulfonamide hybrid scaffold as a promising anticancer agent

    Article • Journal of Biomolecular Structure and Dynamics, October 2022, Taylor & Francis

    Dr. Moataz Ahmed Shaldam

  29. Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii

    Article • Journal of Applied Microbiology, October 2022, Oxford University Press (OUP)

    Dr. Moataz Ahmed Shaldam

  30. Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene

    Article • Pharmaceuticals, August 2022, MDPI AG

    Dr. Moataz Ahmed Shaldam

  31. Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, In Vitro, and In Vivo Approaches

    Article • Antibiotics, July 2022, MDPI AG

    Dr. Moataz Ahmed Shaldam

  32. Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa

    Article • Microorganisms, May 2022, MDPI AG

    Dr. Moataz Ahmed Shaldam

  33. Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2022, Taylor & Francis

    Dr. Moataz Ahmed Shaldam, Wagdy Eldehna

  34. Multi-Spectroscopic, thermodynamic and molecular dynamic simulation studies for investigation of interaction of dapagliflozin with bovine serum albumin

    Article • Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, January 2022, Elsevier

    Dr. Moataz Ahmed Shaldam

  35. Virtual Screening Attributes Male Biased COVID-19 Mortality to Predicted Antiviral Activity of Female Sex Hormones

    Article • Letters in Drug Design & Discovery, November 2021, Bentham Science Publishers

    PhD Basem Awad Mansour, Dr. Moataz Ahmed Shaldam, Kristina Keuper, Galal Metwally, Ahmed El-Baz

  36. A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in Pseudomonas aeruginosa

    Article • Antibiotics, November 2021, MDPI AG

    Dr. Moataz Ahmed Shaldam

  37. Secnidazole Is a Promising Imidazole Mitigator of Serratia marcescens Virulence

    Article • Microorganisms, November 2021, MDPI AG

    Dr. Moataz Ahmed Shaldam

  38. Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Dr. Moataz Ahmed Shaldam, Wagdy Eldehna

  39. Could the analgesic drugs, paracetamol and indomethacin, function as quorum sensing inhibitors?

    Article • Microbial Pathogenesis, September 2021, Elsevier

    Dr. Moataz Ahmed Shaldam

  40. Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon

    Article • Antibiotics, July 2021, MDPI AG

    Dr. Moataz Ahmed Shaldam

  41. Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens

    Article • Microorganisms, May 2021, MDPI AG

    Dr. Moataz Ahmed Shaldam

  42. In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes

    Article • Environmental Science and Pollution Research, May 2021, Springer Science + Business Media

    Dr. Moataz Ahmed Shaldam, Dr Mohamed M Abdel-Daim

  43. Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors

    Article • European Journal of Medicinal Chemistry, April 2021, Elsevier

    Dr. Moataz Ahmed Shaldam, Wagdy Eldehna

  44. New thiazolopyrimidine as anticancer agents: Synthesis, biological evaluation, DNA binding, molecular modeling and ADMET study

    Article • Bioorganic & Medicinal Chemistry Letters, December 2020, Elsevier

    Dr. Moataz Ahmed Shaldam

  45. In Silico Screening of Potent Bioactive Compounds from Honey Bee Products Against COVID-19 Target Enzymes

    Article • July 2020, American Chemical Society (ACS)

    Dr. Moataz Ahmed Shaldam

  46. Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 2020, Springer Science + Business Media

    Dr. Moataz Ahmed Shaldam

  47. Novel Pyruvate Kinase (PK) Inhibitors: New Target to Overcome Bacterial Resistance

    Article • ChemistrySelect, March 2020, Wiley

    Dr. Moataz Ahmed Shaldam

  48. Synthesis of imidazolidine‐2,4‐dione and 2‐thioxoimidazolidin‐4‐one derivatives as inhibitors of virulence factors production in Pseudomonas aeruginosa

    Article • Archiv der Pharmazie, March 2020, Wiley

    Hisham Abbas, Dr. Moataz Ahmed Shaldam

  49. Curtailing Quorum Sensing in Pseudomonas aeruginosa by Sitagliptin

    Article • Current Microbiology, February 2020, Springer Science + Business Media

    Dr. Moataz Ahmed Shaldam

  50. Synthesis and Antibacterial Evaluation of New2‐Phenylbenzimidazole Derivatives

    Article • ChemistrySelect, September 2019, Wiley

    Dr. Moataz Ahmed Shaldam

  51. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus

    Article • African Health Sciences, April 2019, African Journals Online (AJOL)

    Dr. Moataz Ahmed Shaldam

  52. Perturbation of Quorum Sensing in <i>Pseudomonas aeruginosa</i> by Febuxostat

    Article • Advances in Microbiology, January 2018, Scientific Research Publishing, Inc,

    Dr. Moataz Ahmed Shaldam

  53. Repurposing metformin as a quorum sensing inhibitor in <i>Pseudomonas aeruginosa</i>

    Article • African Health Sciences, September 2017, African Journals Online (AJOL)

    Dr. Moataz Ahmed Shaldam

  54. Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography

    Article • Journal of Chromatographic Science, August 2017, Oxford University Press (OUP)

    Dr. Moataz Ahmed Shaldam

  55. Glyceryl trinitrate is a novel inhibitor of quorum sensing in <i>Pseudomonas aeruginosa</i>

    Article • African Health Sciences, March 2017, African Journals Online (AJOL)

    Dr. Moataz Ahmed Shaldam

  56. Synthesis, Evaluation of Pharmacological Activity, and Molecular Docking of 1,4-Dihydropyridines as Calcium Antagonists

    Article • Chemical and Pharmaceutical Bulletin, January 2016, Pharmaceutical Society of Japan

    Dr. Moataz Ahmed Shaldam

  57. Applying green analytical chemistry (GAC) for development of stability indicating HPLC method for determining clonazepam and its related substances in pharmaceutical formulations and calculating uncertainty

    Article • Arabian Journal of Chemistry, November 2014, Elsevier

    Dr. Moataz Ahmed Shaldam

  58. 1,4-Dihydropyridine Calcium Channel Blockers: Homology Modeling of the Receptor and Assessment of Structure Activity Relationship

    Article • ISRN Medicinal Chemistry, February 2014, Hindawi Publishing Corporation

    Dr. Moataz Ahmed Shaldam